DANIEL N. SWISHER, JR.

Corporate Board Profile

Tech Score: 0/100

CERUS CORP

Filing Date	Source Excerpt
2012-04-26	Daniel N. Swisher Jr., 49, has served as a member of our Board since June 2011. The Nominating and Corporate Governance Committee concluded that Mr. Swisher continues to be a valuable member of the Board in part due to his extensive financial management expertise as the former Chief Financial Officer of Sunesis Pharmaceuticals, Inc., or Sunesis, and his industry expertise as the current President and Chief Executive Officer of Sunesis. Mr. Swisher has served as the Chief Executive Officer of Sunesis, and a member of its board of directors since January 2004 and as its President since August 2005. From December 2001 to December 2003, he served as the Chief Business Officer and Chief Financial Officer of Sunesis. From June 1992 to September 2001, Mr. Swisher served in various management roles, including Senior Vice President of Sales and Marketing, for ALZA Corporation. Mr. Swisher holds a B.A. in history from Yale University and an M.B.A. from the Stanford Graduate School of Business. The Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information for fiscal 2011 for each of the Board committees: Daniel N. Swisher Jr.: Audit Committee member, Compensation Committee member, Nominating and Corporate Governance Committee member. Director Compensation Table: Daniel N. Swisher Jr. Fees Earned or Paid in Cash $19,500, Option Awards $42,260, Total $61,760.
2021-04-23	Daniel N. Swisher Jr., 58, has served as a member of our Board since June 2011 and has served as Chair of the Board since October 2013... The Compensation Committee currently consists of Ms. Schulze (Chair), Dr. Witney, and Messrs. Swisher and Moore... The following table shows for the fiscal year ended December 31, 2020 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2020... Daniel N. Swisher, Jr. Fees Earned or Paid in Cash($) 81,500, Option Awards($) 106,114, Stock Awards($) 101,672, Total($) 289,286.

Filing Date

Source Excerpt

2012-04-26

Daniel N. Swisher Jr., 49, has served as a member of our Board since June 2011. The Nominating and Corporate Governance Committee concluded that Mr. Swisher continues to be a valuable member of the Board in part due to his extensive financial management expertise as the former Chief Financial Officer of Sunesis Pharmaceuticals, Inc., or Sunesis, and his industry expertise as the current President and Chief Executive Officer of Sunesis. Mr. Swisher has served as the Chief Executive Officer of Sunesis, and a member of its board of directors since January 2004 and as its President since August 2005. From December 2001 to December 2003, he served as the Chief Business Officer and Chief Financial Officer of Sunesis. From June 1992 to September 2001, Mr. Swisher served in various management roles, including Senior Vice President of Sales and Marketing, for ALZA Corporation. Mr. Swisher holds a B.A. in history from Yale University and an M.B.A. from the Stanford Graduate School of Business. The Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information for fiscal 2011 for each of the Board committees: Daniel N. Swisher Jr.: Audit Committee member, Compensation Committee member, Nominating and Corporate Governance Committee member. Director Compensation Table: Daniel N. Swisher Jr. Fees Earned or Paid in Cash $19,500, Option Awards $42,260, Total $61,760.

2021-04-23

Daniel N. Swisher Jr., 58, has served as a member of our Board since June 2011 and has served as Chair of the Board since October 2013... The Compensation Committee currently consists of Ms. Schulze (Chair), Dr. Witney, and Messrs. Swisher and Moore... The following table shows for the fiscal year ended December 31, 2020 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2020... Daniel N. Swisher, Jr. Fees Earned or Paid in Cash($) 81,500, Option Awards($) 106,114, Stock Awards($) 101,672, Total($) 289,286.

CORCEPT THERAPEUTICS INC

Filing Date	Source Excerpt
2016-04-22	Mr. Swisher is CEO of Sunesis Pharmaceuticals and Chairman of Cerus Corporation, with a B.A. from Yale University and an M.B.A. from Stanford Graduate School of Business.
2017-04-21	Daniel N. Swisher, Jr. became a member of our Board in June 2015. He has been the Chief Executive Officer and a member of the Board of Sunesis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, since 2003, and its President since 2005. Mr. Swisher holds a B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business.
2018-04-24	Daniel N. Swisher, Jr. became a member of our Board in June 2015. He has been the President and Chief Operating Officer of Jazz Pharmaceuticals since January 2018. From 2003 to December 2017, he was Chief Executive Officer and a member of the board of directors of Sunesis Pharmaceuticals, a clinical-stage biopharmaceutical company. He joined Sunesis in 2001 and had previously served as the company’s chief business officer and chief financial officer.
2019-04-24	Daniel N. Swisher, Jr. is President and COO of Jazz Pharmaceuticals and former CEO of Sunesis Pharmaceuticals. He holds a B.A. from Yale and an M.B.A. from Stanford Graduate School of Business.
2020-04-27	Mr. Swisher received his B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance.
2021-04-22	Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance.
2022-04-25	Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance.
2023-04-14	Mr. Swisher has been the President of Jazz Pharmaceuticals and CEO of Sunesis Pharmaceuticals, a clinical-stage biopharmaceutical company. He received his B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business.
2024-04-10	Mr. Swisher received his B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance.

Jazz Pharmaceuticals plc

Filing Date	Source Excerpt
2021-08-30	Daniel N. Swisher, Jr. included in the list of directors with no indication of software or technical background.

Protagonist Therapeutics, Inc

Filing Date	Source Excerpt
2024-04-26	Mr. Swisher received a B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business.

Viracta Therapeutics, Inc.

Filing Date	Source Excerpt
2008-04-29	Daniel N. Swisher, Jr. has served as our Chief Executive Officer, or CEO, and a member of our Board of Directors since January 2004 and also as our President since August 2005. ... Mr. Swisher holds a B.A. in History from Yale University and an M.B.A. from the Stanford Graduate School of Business.
2009-05-20	Daniel N. Swisher, Jr. has served as our Chief Executive Officer, or CEO, and a member of our Board since January 2004 and also as our President since August 2005. ... The compensation received by Mr. Swisher, as a named executive officer, is set forth in the Summary Compensation Table on page 30 of this proxy statement.
2011-04-21	Daniel N. Swisher, Jr. has served as our Chief Executive Officer, or CEO, and a member of our Board since January 2004 and also as our President since August 2005. ... The compensation received by Mr. Swisher, as a named executive officer, is set forth in the Executive Compensation and Related Information—Summary Compensation Table on page 41 of this proxy statement.
2012-04-23	Daniel N. Swisher, Jr. has served as our Chief Executive Officer, or CEO, and a member of our Board since January 2004 and also as our President since August 2005. The Board has concluded that Mr. Swisher should serve on our Board due to his long tenure as our CEO. Our CEO did not receive any additional compensation in 2011 for his service on our Board.
2014-04-24	Daniel N. Swisher, Jr. has served as our Chief Executive Officer, or CEO, and a member of our Board since January 2004 and also as our President since August 2005. The CEO did not receive any additional compensation in 2013 for his service on our Board. His compensation as a named executive officer is detailed separately.
2016-04-25	Daniel N. Swisher, Jr. has served as our Chief Executive Officer and a member of our Board since January 2004. The Summary Compensation Table shows total compensation of $1,230,819.
2017-04-20	Daniel N. Swisher, Jr. has served as our Chief Executive Officer, or CEO, and a member of our Board since January 2004 and also as our President since August 2005. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2016. Mr. Swisher's compensation as a named executive officer is set forth in the Executive Compensation and Related Information section. ... The Summary Compensation Table shows Mr. Swisher's total compensation for 2016 was $1,544,343.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22